|
|
| Line 1: |
Line 1: |
| [[Image:1a1x.gif|left|200px]] | | {{Seed}} |
| | [[Image:1a1x.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1a1x| PDB=1a1x | SCENE= }} | | {{STRUCTURE_1a1x| PDB=1a1x | SCENE= }} |
|
| |
|
| '''CRYSTAL STRUCTURE OF MTCP-1 INVOLVED IN T CELL MALIGNANCIES'''
| | ===CRYSTAL STRUCTURE OF MTCP-1 INVOLVED IN T CELL MALIGNANCIES=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Two related oncogenes, TCL-1 and MTCP-1, are overexpressed in T cell prolymphocytic leukemias as a result of chromosomal rearrangements that involve the translocation of one T cell receptor gene to either chromosome 14q32 or Xq28. The crystal structure of human recombinant MTCP-1 protein has been determined at 2.0 A resolution by using multiwavelength anomalous dispersion data from selenomethionine-enriched protein and refined to an R factor of 0.21. MTCP-1 folds into a compact eight-stranded beta barrel structure with a short helix between the fourth and fifth strands. The topology is unique. The structure of TCL-1 has been predicted by molecular modeling based on 40% amino acid sequence identity with MTCP-1. The identical residues are clustered inside the barrel and on the surface at one side of the barrel. The overall structure of MTCP-1 superficially resembles the structures of proteins in the lipocalin family and calycin superfamily. These proteins have diverse functions, including transport of retinol, fatty acids, chromophores, pheromones, synthesis of prostaglandin, immune modulation, and cell regulation. However, MTCP-1 differs in the topology of the beta strands. The structural similarity suggests that MTCP-1 and TCL-1 form a unique family of beta barrel proteins that is predicted to bind small hydrophobic ligands and function in cell regulation.
| | The line below this paragraph, {{ABSTRACT_PUBMED_9520380}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 9520380 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_9520380}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| Line 35: |
Line 39: |
| [[Category: Oncogene involved in t cell malignancy]] | | [[Category: Oncogene involved in t cell malignancy]] |
| [[Category: Proto-oncogene]] | | [[Category: Proto-oncogene]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 09:41:20 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 15:49:09 2008'' |
